Western New York BloodCare, Buffalo
Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
Weill Cornell Medical College - New York Presbyterian Hospital, New York
dan 2 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Mount Sinai Medical Center, New York
Jacobi Medical Center, The Bronx

Menerima pesertaFase 2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Agu 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

Jacobi Medical Center, The Bronx

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07224360

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Richmond University Medical Center- Site Number : 8400038, Staten Island
Montefiore Medical Center - Moses Campus- Site Number : 8400057, The Bronx

Menerima pesertaFase 3

Usia 10 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06975865

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

New York Medical College, Valhalla

Menerima pesertaFase 2

6 Months – 21 Years · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT02675959

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering, New York

Menerima pesertaFase 1/2

Usia 12 hingga 50 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT04819841

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

Columbia University Irving Medical Center, New York

Menerima pesertaFase 1

Usia 12 hingga 50 · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT07015684

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Roswell Park (MRD-HCT), Buffalo
Columbia Presbytarian (NT-DMT), New York
Cohen's Children Hospital (NT-DMT), Queens
dan 4 lainnya

Menerima pesertaStudi observasional

Usia 3 hingga 20 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06941389

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
Memorial Sloan Kettering Westchester (Consent only), Harrison
Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre

Menerima pesertaFase 2

Usia 2 hingga 50 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05736419

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York

Menerima pesertaFase 3

Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT05477563

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

Columbia University, New York

Menerima pesertaFase 2

Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT03587272

A Long-term Follow-up Study in Patients Who Received BEAM-101

Columbia University Irving Medical Center, New York

Menerima pesertaStudi observasional

Usia 14 hingga 37 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT07373639

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Weil Cornell Medical College, New York
University of Rochester Medical Center, Rochester

Menerima peserta

Usia 16 hingga 30 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT06374238

Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain

Mount Sinai Hospital, New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2025 · NCT05519111

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

New York Medical College, Valhalla

Menerima pesertaFase 2

1 Day – 30 Years · Semua jenis kelamin · Diperbarui 8 Agu 2025 · NCT04099966

Cannabidiol in Sickle Cell Disease

Icahn School of Medicine at Mount Sinai, Manhattan

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2025 · NCT06930703

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.